New diabetes combo pill put to the test in healthy volunteers
NCT ID NCT07519265
First seen Apr 11, 2026 · Last updated May 14, 2026 · Updated 6 times
Summary
This study checks if a new tablet that combines two diabetes drugs (Chiglitazar and Metformin) is absorbed the same way as the standard separate tablets. It involves 64 healthy adults aged 18-45 who take a single dose of each version after a meal. The goal is to see if the new combo pill works just as well, not to treat diabetes directly.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for T2DM (TYPE 2 DIABETES MELLITUS) are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.